Search research articles
Contact Us
Filters
Showing results (151-160 of 165) with videos related to
Page
of 17
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
February 18, 2025
The Crosstalk with CXCL10-Rich Tumor-Associated Mast Cells Fuels Pancreatic Cancer Progression and Immune Escape
Hanlin Yin, Qiangda Chen, Shanshan Gao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 20, 2026
Pathomics Signature for Prognosis and CA19-9 Interception in Pancreatic Ductal Adenocarcinoma: A Real-Life, Multi-Center Study
Qiangda Chen, Zhihang Xu, Yiping Zou, et al.
Oncology Letters
|
March 7, 2024
Efficacy of nab‑paclitaxel vs. Gemcitabine in combination with S‑1 for advanced pancreatic cancer: A multicenter phase II randomized trial
Xi Guo, Wenhui Lou, Yaolin Xu, et al.
Journal of Hematology & Oncology
|
November 26, 2022
Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma
Yexin Tong, Mingjun Sun, Lingli Chen, et al.
The Lancet. Oncology
|
September 23, 2020
Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study
Jianming Xu, Lin Shen, Chunmei Bai, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
July 28, 2023
Is surgical resection justified for pancreatic ductal adenocarcinoma with distant abdominal organ metastasis? A position paper by experts in pancreatic surgery at the Joint Meeting of the International Association of Pancreatology (IAP) & the Japan Pancreas Society (JPS) 2022 in Kyoto
Daisuke Hashimoto, Sohei Satoi, Tsutomu Fujii, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
November 16, 2023
Baseline radiologic features as predictors of efficacy in patients with pancreatic neuroendocrine tumors with liver metastases receiving surufatinib
Jianwei Zhang, Haibin Zhu, Lin Shen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 30, 2025
Surufatinib in advanced neuroendocrine tumours: Final overall survival from two randomised, double-blind, placebo-controlled phase 3 studies (SANET-ep and SANET-p)
Jianming Xu, Lin Shen, Jie Li, et al.
Cancers
|
February 25, 2022
Fate of Surgical Patients with Small Nonfunctioning Pancreatic Neuroendocrine Tumors: An International Study Using Multi-Institutional Registries
In Woong Han, Jangho Park, Eun Young Park, et al.
Nature Communications
|
February 2, 2022
Multiplexed nanomaterial-assisted laser desorption/ionization for pan-cancer diagnosis and classification
Hua Zhang, Lin Zhao, Jingjing Jiang, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 165) with videos related to
Sort By:
Page
of 17
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
February 18, 2025
The Crosstalk with CXCL10-Rich Tumor-Associated Mast Cells Fuels Pancreatic Cancer Progression and Immune Escape
Hanlin Yin, Qiangda Chen, Shanshan Gao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 20, 2026
Pathomics Signature for Prognosis and CA19-9 Interception in Pancreatic Ductal Adenocarcinoma: A Real-Life, Multi-Center Study
Qiangda Chen, Zhihang Xu, Yiping Zou, et al.
Oncology Letters
|
March 7, 2024
Efficacy of nab‑paclitaxel vs. Gemcitabine in combination with S‑1 for advanced pancreatic cancer: A multicenter phase II randomized trial
Xi Guo, Wenhui Lou, Yaolin Xu, et al.
Journal of Hematology & Oncology
|
November 26, 2022
Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma
Yexin Tong, Mingjun Sun, Lingli Chen, et al.
The Lancet. Oncology
|
September 23, 2020
Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study
Jianming Xu, Lin Shen, Chunmei Bai, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
July 28, 2023
Is surgical resection justified for pancreatic ductal adenocarcinoma with distant abdominal organ metastasis? A position paper by experts in pancreatic surgery at the Joint Meeting of the International Association of Pancreatology (IAP) & the Japan Pancreas Society (JPS) 2022 in Kyoto
Daisuke Hashimoto, Sohei Satoi, Tsutomu Fujii, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
November 16, 2023
Baseline radiologic features as predictors of efficacy in patients with pancreatic neuroendocrine tumors with liver metastases receiving surufatinib
Jianwei Zhang, Haibin Zhu, Lin Shen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 30, 2025
Surufatinib in advanced neuroendocrine tumours: Final overall survival from two randomised, double-blind, placebo-controlled phase 3 studies (SANET-ep and SANET-p)
Jianming Xu, Lin Shen, Jie Li, et al.
Cancers
|
February 25, 2022
Fate of Surgical Patients with Small Nonfunctioning Pancreatic Neuroendocrine Tumors: An International Study Using Multi-Institutional Registries
In Woong Han, Jangho Park, Eun Young Park, et al.
Nature Communications
|
February 2, 2022
Multiplexed nanomaterial-assisted laser desorption/ionization for pan-cancer diagnosis and classification
Hua Zhang, Lin Zhao, Jingjing Jiang, et al.
Page
of 17